Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Prof Michael Gillies
+44 131 242 1642
michael.gillies@nhslothian.scot.nhs.uk


More information about this study, what is involved and how to take part can be found on the study website.

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A randomised trial to investigate whether giving more blood transfusions to people undergoing surgery for hip fracture improves their outcomes

A randomised trial to investigate whether giving more blood transfusions to people undergoing surgery for hip fracture improves their outcomes

Medical Conditions

Blood transfusion for recovery from hip surgery


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Hip fracture is the most common serious injury in older people. More than 95% of patients have surgery. This surgery is often high-risk as patients may be frail and have other health problems including heart disease and anaemia (a low blood count). Patients may be in hospital for a long time and need rehabilitation. Up to 35% of surviving patients do not return to their original residence and have a high rate of increased dependency.
Research suggests that 30-40% of these patients have a blood transfusion around the time of operation. However, doctors are uncertain about what level of anaemia transfusions should be given at. Many current guidelines recommend transfusion at a lower level, but there is research which suggests that this level is too low particularly if the patient has a history of heart disease. In these patients, transfusion at a higher level may be better to prevent complications.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Jun 2022 30 Apr 2026

Participants will be randomly assigned to either receive blood transfusions at a lower blood count, in line with current guidelines, or a higher level, for the duration of their hospital stay, or 30 days, whichever is soonest.
Patients will have their blood count checked before and after any blood transfusions and will have additional blood tests (Troponin) and heart tracings (electrocardiographs, (ECG)) to check their heart.
At 30 days we will measure how often post-operative heart attacks and other complications occur, how long patients stay in hospital and mortality rate. At 30 and 120 days we will measure quality of life (assessed by questionnaire).
The study will last for 4 years but each patient will only be active in the study for 120 days. The study results will help doctors looking after people with hip fracture decide when is the best time to give blood transfusions


Older (60 years or older) people with a hip fracture and anaemia

You can take part if:



You may not be able to take part if:


Current exclusion criteria as of 03/07/2025:

1. Objection to RBC transfusion2. Unable to obtain consent (from patient or in accordance with appropriate mental capacity legislation for site)3. Patients for non-operative management or not expected to survive 48 hours4. Patients with a new or suspected acute coronary syndrome meeting 4th Universal Definition during current admission5. Rapid or uncontrolled blood loss resulting in haemodynamic instability6. Chronic anaemia requiring repeated transfusion (eg Myelodysplasia or bone marrow failure syndromes)

_____

Previous participant exclusion criteria as of 17/11/2023:

1. Objection to RBC transfusion2. Unable to obtain consent (from patient or in accordance with appropriate mental capacity legislation for site)3. Patients for non-operative management or not expected to survive 48 hours4. Patients with a new or suspected acute coronary syndrome meeting 4th Universal Definition during current admission5. Rapid or uncontrolled blood loss resulting in haemodynamic instability6. Transfusion dependent/chronic anaemias (eg Myelodysplasia or bone marrow failure syndromes)

_____

Previous participant exclusion criteria:

1. Objection to RBC transfusion2. Unable to obtain consent (from patient or in accordance with appropriate mental capacity legislation for site)3. Patients for non-operative management or not expected to survive 48 hours4. Patients with a new acute coronary syndrome meeting 4th Universal Definition during current admission5. Rapid or uncontrolled blood loss resulting in haemodynamic instability


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Southmead Hospital
    Southmead Road Westbury-on-trym
    Bristol
    BS10 5NB
  • Croydon University Hospital
    London Road
    Croydon
    CR7 7YE
  • Aberdeen Royal Infirmary
    Foresterhill Road
    Aberdeen
    AB25 2ZN
  • John Radcliffe Hospital
    Headley Way Headington
    Oxford
    OX3 9DU
  • Southampton General Hospital
    Tremona Road
    Southampton
    SO16 6YD
  • Glasgow Royal Infirmary
    84 Castle Street
    Glasgow
    G4 0SF
  • The James Cook University Hospital
    Marton Road
    Middlesbrough
    TS4 3BW
  • North Devon District Hospital
    Raleigh Park
    Barnstaple
    EX31 4JB
  • Leicester Royal Infirmary
    Infirmary Square
    Leicester
    LE1 5WW
  • Worcestershire Royal Hospital
    Charles Hastings Way
    Worcester
    WR5 1DD
  • East Surrey Hospital
    Canada Avenue
    Redhill
    RH1 5RH
  • Stoke Mandeville Hospital
    Mandeville Road
    Aylesbury
    HP21 8AL
  • Darlington Memorial Hospital
    Hollyhurst Road
    Darlington
    DL3 6HX
  • Royal Infirmary of Edinburgh at Little France
    51 Little France Crescent Old Dalkeith Road Edinburgh
    Lothian
    EH16 4SA
  • Wishaw General Hospital
    50 Netherton Street
    Wishaw
    ML2 0DP
  • Hull University Teaching Hospitals NHS Trust
    Hull Royal Infirmary Anlaby Road
    Hull
    HU3 2JZ
  • Rotherham General Hospital
    Moorgate Road
    Rotherham
    S60 2UD
  • Royal Devon and Exeter Hospital
    Royal Devon & Exeter Hospital Barrack Road
    Exeter
    EX2 5DW
  • Norfolk and Norwich University Hospital
    Colney Lane Colney
    Norwich
    NR4 7UY
  • Ipswich Hospital
    Heath Road
    Ipswich
    IP4 5PD
  • Hereford County Hospital
    Stonebow Road
    Hereford
    HR1 2BN
  • University Hospital of North Tees
    Hardwick Road
    Stockton-on-tees
    TS19 8PE
  • Royal Albert Edward Infirmary
    Wigan Lane
    Wigan
    WN1 2NN
  • Borders General Hospital
    Huntlyburn Terrace
    Melrose
    TD6 9BS
  • The Princess Alexandra Hospital NHS Trust
    Hamstel Road
    Harlow
    CM20 1QX
  • Royal Victoria Hospital
    Queen Victoria Road
    Newcastle upon Tyne
    NE1 4LP
  • Dumfries and Galloway Royal Infirmary
    Bankend Road Dumfries
    Dumfries and Galloway
    DG1 4AP
  • Victoria Hospital
    Hayfield Road
    Kirkcaldy
    KY25AH
  • Horton General Hospital
    81a Oxford Road
    Banbury
    OX16 9AL
  • University Hospital of North Durham Cdc
    University Hospital of North Durham North Road
    Durham
    DH1 5TW
  • Southport and Formby District General Hospital
    Town Lane
    Southport
    PR8 6PN

Benefits: There are no clear benefits of taking part in the study. Participants in the liberal arm of the study may receive a few additional transfusions than they would have had if they had not participated in the trial and participants in the restrictive arm may receive slightly fewer transfusions. One arm may be beneficial to participants but we do not know which and are conducting the study to try and find out.
Risks: Blood transfusions are generally very safe but they do carry risks. Transfusion reactions can occur but these are rare and usually mild (for example a fever or rash). Transfusions also have an increased risk of infections or pulmonary oedema although these are very rare.

Prof Michael Gillies
+44 131 242 1642
michael.gillies@nhslothian.scot.nhs.uk



More information about this study, what is involved and how to take part can be found on the study website.


The study is sponsored by University of Edinburgh and NHS Lothian Health Board and funded by NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC); National Institute for Health Research.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN28818784

Or CPMS 52646

Last updated 12 August 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.